ALKBH5 and ovarian cancer: found that the high expression of Toll‐like receptor (TLR4) activates the NF‐κB pathway and upregulates ALKBH5, and the expression of NANOG increases after mRNA demethylation, thus enhancing the invasiveness of ovarian cancer cells.